Orpyx® Receives Award for "Coolest Technology"
Calgary, AB April 21, 2015 - Orpyx Medical Technologies Inc. (“Orpyx”) participated in the pitch competition at the 48 Hours in the Hub event, an annual intensive two-day program in Cambridge/Boston. Orpyx’s President, Lew Turnquist, competed against other Canadian companies in the Life Sciences/ Health IT stream and was awarded the prize for “Coolest Technology”. The award was delivered by Gaurav Jain, who was recently named one of Forbes’ 30 under 30 in Venture Capital 2015.
The Consulate General of Canada in Boston and the Canadian Entrepreneurs in New England (CENE) selected 24 innovative Canadian companies to participate in the 48 Hours in the Hub event. It is an opportunity for Canadian companies to gain visibility in the local Boston business and investment community.
The CENE (Canadian Entrepreneurs in New England) is a non-profit, member-driven organization dedicated to supporting Canadian technology and life science entrepreneurship. It is comprised of a select group of Canadians based primarily in the U.S., including executives of leading technology and life-sciences companies, experienced start-up entrepreneurs and venture capital investors.
ABOUT ORPYX MEDICAL TECHNOLOGIES:
Orpyx is a wearable pressure sensor technology company focused on medical applications. To start, Orpyx’s primary intention is to address the world’s growing epidemic of diabetes and its associated complications, most notably, lack of circulation, numbness, infection and ulcers in the feet, also known as peripheral neuropathy. This problem affects upwards of 60% of diabetics over the course of their disease and costs the health care system over $14 billion annually.
The SurroSense Rx system is a tool to help actively prevent the complications associated with peripheral neuropathy and track progress. The system is comprised of pressure-sensing inserts that wirelessly transmit feedback to the user via smartwatch or mobile application. The display alerts the user as to when pressure-induced damage is occurring so that behaviour can be proactively changed and devastating complications avoided.
In addition to the benefits of having real-time feedback, the system also tracks compliance and performance metrics over time so that the patient and primary care team and monitor progress and adjust care recommendations accordingly.
For more information, please contact:
Marketing & Inside Sales Manager, Orpyx Medical Technologies Inc.